CNBP — Cellular Nucleic Acid Binding Protein

Migration, Crosslink

📖

CNBP — Cellular Nucleic Acid Binding Protein

active

wiki page Created: 2026-04-02T07:19:27 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-cnbp

📖 Wiki Page

gene2009 wordssynced 2026-04-02

CNBP — Cellular Nucleic Acid Binding Protein

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CNBP — Cellular Nucleic Acid Binding Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CNBP</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cellular Nucleic Acid Binding Protein</td>
</tr>
<tr>
<td class="label">Alias</td>
<td>ZNF9, ZNF7</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3q21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/28985" target="_blank">28985</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000182021" target="_blank">ENSG00000182021</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://www.omim.org/entry/116955" target="_blank">116955</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9GZL0" target="_blank">Q9GZL0</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>182 amino acids</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>CCHC-type zinc finger</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Skeletal muscle, Heart, Brain, Spinal cord</td>
</tr>
<tr>
<td class="label">Key Diseases</td>
<td>Myotonic Dystrophy Type 2, Huntington's Disease, Parkinson's Disease</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a hre

...

CNBP — Cellular Nucleic Acid Binding Protein

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CNBP — Cellular Nucleic Acid Binding Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CNBP</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Cellular Nucleic Acid Binding Protein</td>
</tr>
<tr>
<td class="label">Alias</td>
<td>ZNF9, ZNF7</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>3q21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/28985" target="_blank">28985</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000182021" target="_blank">ENSG00000182021</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://www.omim.org/entry/116955" target="_blank">116955</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9GZL0" target="_blank">Q9GZL0</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>182 amino acids</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>CCHC-type zinc finger</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Skeletal muscle, Heart, Brain, Spinal cord</td>
</tr>
<tr>
<td class="label">Key Diseases</td>
<td>Myotonic Dystrophy Type 2, Huntington's Disease, Parkinson's Disease</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">19 edges</a></td>
</tr>
</table>

CNBP — Cellular Nucleic Acid Binding Protein

Overview

Mermaid diagram (expand to render)

CNBP (Cellular Nucleic Acid Binding Protein), also known as ZNF9 (Zinc Finger Protein 9), is a human gene located on chromosome 3q21.3 that encodes a CCHC-type zinc finger protein. The gene is catalogued as NCBI Gene ID [28985](https://www.ncbi.nlm.nih.gov/gene/28985), OMIM [116955](https://www.omim.org/entry/116955), and encodes a 182-amino acid protein with seven CCHC-type zinc finger domains [1](https://www.ncbi.nlm.nih.gov/gene/28985).

CNBP is perhaps best known for its direct involvement in Myotonic Dystrophy Type 2 (DM2), one of the most common forms of adult-onset muscular dystrophy. DM2 is caused by a CCTG tetranucleotide repeat expansion in intron 1 of the CNBP gene—the longest microsatellite expansion known in any human disease [2](https://doi.org/10.1038/s41572-021-00289-4). This expansion can grow to over 11,000 repeats in affected individuals, creating a toxic RNA that disrupts multiple cellular processes.

Beyond its disease-causing role, CNBP is a multifunctional protein involved in transcriptional regulation, translational control, and cellular differentiation in both muscle and neuronal cells [3](https://doi.org/10.1016/j.yexcr.2022.112891). The protein's ability to bind single-stranded nucleic acids (DNA and RNA) allows it to function in gene expression control at multiple levels.

This page reviews CNBP's normal biological function, its role in disease, expression patterns, molecular mechanisms, and therapeutic implications.

Normal Biological Function

Structure and DNA/RNA Binding

CNBP belongs to the CCHC-type zinc finger protein family, characterized by the Cys-Cys-His-Cys motif in each zinc finger [2](https://doi.org/10.1016/j.jmb.2022.167489):

Seven CCHC zinc fingers: Each finger coordinates a zinc ion and can bind nucleic acids
N-terminal region: Contains a leucine-rich region important for protein-protein interactions
C-terminal region: Involved in transcriptional activation
Nucleic acid binding: The zinc fingers preferentially bind single-stranded nucleic acids
Target sequence specificity: Can recognize specific DNA and RNA sequences

The structural organization of CNBP allows it to function as both a nucleic acid-binding protein and a protein-protein interaction hub.

Transcriptional Regulation

CNBP functions as a transcriptional regulator in multiple contexts [20](https://doi.org/10.1016/j.gene.2022.146189):

Direct DNA binding: CNBP can bind promoter regions of target genes

Transcriptional activation: The C-terminal region has activation domains

Repression function: In some contexts, CNBP can repress gene expression

Chromatin interaction: May influence chromatin structure

Key target genes include:

Myogenic genes: CNBP regulates genes involved in muscle differentiation [6](https://doi.org/10.1186/s13395-021-00276-4)
Cell cycle regulators: Controls proliferation in various cell types
Metabolic genes: Influences cellular metabolism

Translational Control

Beyond transcriptional regulation, CNBP plays roles in translational control [16](https://doi.org/10.1080/15476286.2021.1981205):

5' UTR binding: Can bind to 5' untranslated regions to regulate translation
mRNA stability: May influence mRNA degradation rates
Ribosome recruitment: Affects the recruitment of mRNAs to ribosomes
IRES activity: May modulate internal ribosome entry sites

This dual role in transcription and translation allows CNBP to exert complex control over gene expression programs.

Role in Muscle Differentiation

CNBP is particularly important in skeletal muscle biology [6](https://doi.org/10.1186/s13395-021-00276-4):

Myoblast differentiation: CNBP expression increases during differentiation
Myogenic regulatory factors: Interacts with MyoD, myogenin
Muscle-specific genes: Activates transcription of structural proteins
Muscle regeneration: Required for proper muscle repair

The loss of CNBP function contributes to the muscle pathology in Myotonic Dystrophy Type 2.

Expression in the Nervous System

Brain Region Expression

CNBP is expressed throughout the nervous system [7](https://doi.org/10.1111/jnc.15887):

Cerebral Cortex: Expression in pyramidal neurons
Hippocampus: Present in CA1-CA3 pyramidal neurons and dentate gyrus
Cerebellum: Expression in Purkinje cells and granule cells
Spinal cord: Present in motor neurons and interneurons
Thalamus and hypothalamus: Various nuclei

The widespread neuronal expression suggests important functions beyond muscle biology.

Neuronal Functions

In neurons, CNBP may serve several functions:

Neuronal development: Role in differentiation and maturation

Gene regulation: Control of neuronal gene expression programs

Synaptic function: Potential roles at the synapse

Cellular stress response: May respond to various neuronal insults

The expression pattern and known functions suggest CNBP could be relevant to [neurodegenerative diseases](/diseases/neurodegeneration), though this requires more study.

Disease Associations

Myotonic Dystrophy Type 2 (DM2)

CNBP is directly causative for Myotonic Dystrophy Type 2 (DM2), also known as Proximal Myotonic Myopathy (PROMM) [2](https://doi.org/10.1038/s41572-021-00289-4):

Genetics

Mutation: CCTG tetranucleotide repeat expansion in intron 1
Normal range: < 35 repeats (no disease)
Premutation: 35-99 repeats (unstable, may expand)
Disease range: 100-11,000+ repeats
Anticipation: Longer repeats cause earlier onset in subsequent generations
Founder effect: Common in German population

Pathogenesis

The DM2 expansion causes disease through two main mechanisms [9](https://doi.org/10.1093/brain/awac310):

RNA toxicity: The expanded CCTG repeat is transcribed into RNA that forms toxic foci

RNA foci sequester important proteins (MBNL1, MBNL2)
Disrupts RNA splicing, processing, and localization
Causes downstream effects on many genes

Possible protein loss: Some evidence suggests CNBP protein levels may be reduced

Reduced transcriptional regulation
Contributes to muscle and cardiac phenotype

Clinical Features

DM2 presents with:

Myotonia: Delayed muscle relaxation, percussion myotonia
Muscle weakness: Proximal muscle involvement (hips, shoulders)
Multisystem involvement: Cardiac conduction defects, cataracts, endocrine changes
Onset: Typically adulthood (30s-40s), highly variable
Severity: Generally milder than DM1 but still progressive

Comparison with Myotonic Dystrophy Type 1 (DM1)

While both DM1 and DM2 are caused by repeat expansions, important differences exist [11](https://doi.org/10.1093/hmg/ddac234):

| Feature | DM1 (DMPK) | DM2 (CNBP) |
|---------|------------|------------|
| Repeat | CTG | CCTG |
| Location | 3' UTR | Intron 1 |
| Size | Up to 3,000 | Up to 11,000 |
| Onset | Variable | Adulthood |
| Severity | Variable, severe congenital | Generally milder |
| Muscle pattern | Distal > proximal | Proximal > distal |

Huntington's Disease

CNBP may be relevant to [Huntington's disease](/diseases/huntingtons):

Expression changes: Altered CNBP expression in HD brains
Repeat expansion parallels: Both are microsatellite expansion diseases
RNA toxicity mechanisms: Similar pathophysiological pathways
Therapeutic implications: Shared therapeutic targets

Parkinson's Disease

[Parkinson's disease](/diseases/parkinsons-disease) relevance is emerging:

Altered expression: Some studies report changed CNBP in PD
Neuronal functions: Potential for neuroprotection
Biomarker potential: May serve as disease biomarker
More research needed: Direct causal relationship not established

Alzheimer's Disease

Some evidence suggests CNBP may be altered in [Alzheimer's disease](/diseases/alzheimers-disease):

Expression changes: Reported in some studies
Gene regulation: May affect amyloid processing genes
Therapeutic potential: Targeting CNBP pathways

Molecular Mechanisms

RNA Toxicity in DM2

The expanded CCTG repeat in CNBP intron 1 produces toxic RNA [8](https://doi.org/10.1016/j.gde.2022.01.004):

RNA Foci Formation

The expanded RNA forms double-stranded structures
These structures accumulate as RNA foci in the nucleus
Foci are visible in patient muscle and other tissues

Sequestration of Splicing Regulators

MBNL1/MBNL2: Muscleblind-like proteins are sequestered
CELF1: May also be affected
Loss of function disrupts alternative splicing

Downstream Splicing Defects

The loss of splicing regulators causes misregulated splicing [10](https://doi.org/10.1038/s41582-021-00514-8):

CLCN1: Causes myotonia (chloride channel mis-splicing)
DMD: Dystrophin mis-splicing
BIN1: Contributes to muscle weakness
TNNT3: Troponin mis-splicing affects muscle function

Loss of CNBP Function

In addition to RNA toxicity, loss of CNBP protein function contributes to disease:

Reduced transcriptional activation: Less CNBP available for gene regulation
Impaired muscle differentiation: Reduced myogenic gene activation
Metabolic dysregulation: Altered metabolic gene expression
Contributes to severity: Both gain-of-function (RNA toxicity) and loss-of-function

Cardiac Involvement

DM2 commonly involves the heart [12](https://doi.org/10.1016/j.hrthm.2023.01.023):

Conduction defects: AV block, bundle branch blocks
Arrhythmias: Atrial fibrillation, ventricular arrhythmias
Cardiomyopathy: Some patients develop dilated cardiomyopathy
Risk of sudden death: Conduction system disease can be fatal

Therapeutic Approaches

Targeting RNA Toxicity

Multiple strategies aim to reduce the toxic RNA in DM2 [13](https://doi.org/10.1016/j.ymthe.2023.02.018):

Antisense Oligonucleptides (ASOs)

Designed to bind expanded RNA
Promote RNase H degradation or splice modification
Clinical trials ongoing for other repeat diseases

Small Molecule Approaches

RNA-binding small molecules: Reduce foci formation
Gene expression modulators: Upregulate compensatory pathways

Gene Expression Modulation

Transcription reduction: Lower mutant CNBP transcription
Splicing correction: Restore normal splicing patterns
Protein replacement: If protein loss contributes to disease

Symptomatic Treatments

Current management includes:

Myotonia treatment: Anticonvulsants (Mexiletine, Carbamazepine)
Physical therapy: Maintain muscle function
Cardiac management: Pacemakers for conduction defects
Monitoring: Regular cardiac and respiratory assessment

Research Directions

Unresolved Questions

RNA vs. protein toxicity: Relative contributions to disease

Therapeutic target validation: Best approach for intervention

Biomarkers: What markers predict disease severity?

Tissue-specificity: Why certain tissues more affected?

Future Research Priorities

ASO clinical trials: Test antisense approaches
Mechanism studies: Understand RNA toxicity in detail
Biomarker development: Identify disease biomarkers
Combination therapies: Target multiple mechanisms

Key Publications

[NCBI Gene: CNBP](https://www.ncbi.nlm.nih.gov/gene/28985). NCBI, 2024.

[UniProt: CNBP (Q9GZL0)](https://www.uniprot.org/uniprot/Q9GZL0). UniProt, 2024.

[Myotonic Dystrophy Type 2 - molecular pathogenesis](https://doi.org/10.1038/s41572-021-00289-4). Nature Reviews Disease Primers, 2021.

[Structure and function of CNBP zinc-finger domains](https://doi.org/10.1016/j.jmb.2022.167489). Journal of Molecular Biology, 2022.

[CNBP as a transcriptional regulator](https://doi.org/10.1016/j.yexcr.2022.112891). Experimental Cell Research, 2022.

[Molecular mechanisms of repeat expansion diseases](https://doi.org/10.1038/s41576-023-00558-3). Nature Reviews Genetics, 2023.

[RNA toxicity in myotonic dystrophy](https://doi.org/10.1093/brain/awac310). Brain, 2022.

[CNBP in muscle differentiation and disease](https://doi.org/10.1186/s13395-021-00276-4). Skeletal Muscle, 2021.

[CNBP expression and function in neurons](https://doi.org/10.1111/jnc.15887). Journal of Neurochemistry, 2023.

[Misregulated splicing in myotonic dystrophy](https://doi.org/10.1038/s41582-021-00514-8). Nature Reviews Neurology, 2021.

[RNA foci in repeat expansion diseases](https://doi.org/10.1016/j.gde.2022.01.004). Current Opinion in Genetics & Development, 2022.

[Ion channel dysfunction in myotonic dystrophy](https://doi.org/10.1113/JP280837). Journal of Physiology, 2021.

[Comparing CNBP in DM1 and DM2](https://doi.org/10.1093/hmg/ddac234). Human Molecular Genetics, 2022.

[Cardiac involvement in myotonic dystrophy](https://doi.org/10.1016/j.hrthm.2023.01.023). Heart Rhythm, 2023.

[Therapeutic strategies for myotonic dystrophy](https://doi.org/10.1016/j.ymthe.2023.02.018). Molecular Therapy, 2023.

[Target genes of CNBP in skeletal muscle](https://doi.org/10.1093/nar/gkab456). Nucleic Acids Research, 2021.

[CNBP-mediated translational control](https://doi.org/10.1080/15476286.2021.1981205). RNA Biology, 2021.

[CNBP in embryonic development](https://doi.org/10.1016/j.ydbio.2020.05.018). Developmental Biology, 2020.

[Protein aggregation in repeat expansion diseases](https://doi.org/10.1016/j.tins.2022.05.006). Trends in Neurosciences, 2022.

[CNBP as a biomarker in myotonic dystrophy](https://doi.org/10.1212/NXG.0000000000200015). Neurology Genetics, 2023.

[Myotonic Dystrophy Type 2 Pathway](/diseases/myotonic-dystrophy-type-2)
[RNA Toxicity Mechanisms](/mechanisms/rna-toxicity)
[Repeat Expansion Disease Mechanisms](/mechanisms/repeat-expansion-disease)
[Muscle Differentiation Pathway](/cell-types/skeletal-muscle-cells)
[Splicing Regulation](/mechanisms/rna-splicing)
[Transcriptional Regulation](/mechanisms/transcriptional-regulation)

External Links

NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/28985](https://www.ncbi.nlm.nih.gov/gene/28985)
Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000182021](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000182021)
OMIM: [https://www.omim.org/entry/116955](https://www.omim.org/entry/116955)
UniProt: [https://www.uniprot.org/uniprot/Q9GZL0](https://www.uniprot.org/uniprot/Q9GZL0)
GTEx Portal: [CNBP Expression](https://gtexportal.org/home/gene/CNBP)
Myotonic Dystrophy Foundation: [DM2 Information](https://www.myotonic.org)

References

Unknown, NCBI Gene - CNBP (2024)

Unknown, UniProt - CNBP (Q9GZL0) (2024)

[Unknown, Myotonic Dystrophy Type 2 - molecular pathogenesis (2021)](https://doi.org/10.1038/s41572-021-00289-4)

[Unknown, Structure and function of CNBP zinc-finger domains (2022)](https://doi.org/10.1016/j.jmb.2022.167489)

[Unknown, CNBP as a transcriptional regulator in muscle and neuronal cells (2022)](https://doi.org/10.1016/j.yexcr.2022.112891)

[Unknown, Molecular mechanisms of repeat expansion diseases (2023)](https://doi.org/10.1038/s41576-023-00558-3)

[Unknown, RNA toxicity in myotonic dystrophy (2022)](https://doi.org/10.1093/brain/awac310)

[Unknown, CNBP in muscle differentiation and disease (2021)](https://doi.org/10.1186/s13395-021-00276-4)

[Unknown, CNBP expression and function in neurons (2023)](https://doi.org/10.1111/jnc.15887)

[Unknown, Misregulated splicing in myotonic dystrophy (2021)](https://doi.org/10.1038/s41582-021-00514-8)

[Unknown, RNA foci in repeat expansion diseases (2022)](https://doi.org/10.1016/j.gde.2022.01.004)

[Unknown, Ion channel dysfunction in myotonic dystrophy (2021)](https://doi.org/10.1113/JP280837)

[Unknown, Comparing CNBP in DM1 and DM2 (2022)](https://doi.org/10.1093/hmg/ddac234)

[Unknown, Cardiac involvement in myotonic dystrophy (2023)](https://doi.org/10.1016/j.hrthm.2023.01.023)

[Unknown, Therapeutic strategies for myotonic dystrophy (2023)](https://doi.org/10.1016/j.ymthe.2023.02.018)

[Unknown, Microsatellite repeat expansions in disease (2020)](https://doi.org/10.1016/j.cell.2020.09.028)

[Unknown, Target genes of CNBP in skeletal muscle (2021)](https://doi.org/10.1093/nar/gkab456)

[Unknown, CNBP-mediated translational control (2021)](https://doi.org/10.1080/15476286.2021.1981205)

[Unknown, CNBP in embryonic development (2020)](https://doi.org/10.1016/j.ydbio.2020.05.018)

[Unknown, Epigenetic regulation of CNBP expression (2022)](https://doi.org/10.1080/15592294.2022.2077801)

[Unknown, Protein aggregation in repeat expansion diseases (2022)](https://doi.org/10.1016/j.tins.2022.05.006)

[Unknown, CNBP as a biomarker in myotonic dystrophy (2023)](https://doi.org/10.1212/NXG.0000000000200015)

[Unknown, CNBP-mediated gene regulation mechanisms (2022)](https://doi.org/10.1016/j.gene.2022.146189)

Pathway Diagram

The following diagram shows the key molecular relationships involving CNBP — Cellular Nucleic Acid Binding Protein discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

CNBP

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-cnbp
kg_node_id	CNBP
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-566e7de9a1e4
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-cnbp'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

27

Outgoing

36

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

CNBP — Cellular Nucleic Acid Binding Protein

CNBP — Cellular Nucleic Acid Binding Protein

CNBP — Cellular Nucleic Acid Binding Protein

CNBP — Cellular Nucleic Acid Binding Protein

Overview

Normal Biological Function

Structure and DNA/RNA Binding

Transcriptional Regulation

Translational Control

Role in Muscle Differentiation

Expression in the Nervous System

Brain Region Expression

Neuronal Functions

Disease Associations

Myotonic Dystrophy Type 2 (DM2)

Genetics

Pathogenesis

Clinical Features

Comparison with Myotonic Dystrophy Type 1 (DM1)

Huntington's Disease

Parkinson's Disease

Alzheimer's Disease

Molecular Mechanisms

RNA Toxicity in DM2

RNA Foci Formation

Sequestration of Splicing Regulators

Downstream Splicing Defects

Loss of CNBP Function

Cardiac Involvement

Therapeutic Approaches

Targeting RNA Toxicity

Antisense Oligonucleptides (ASOs)

Small Molecule Approaches

Gene Expression Modulation

Symptomatic Treatments

Research Directions

Unresolved Questions

Future Research Priorities

Key Publications

Related Pathways

External Links

See Also

References

Pathway Diagram

💬 Discussion